跳至主要内容
临床试验/CTRI/2022/06/043008
CTRI/2022/06/043008已完成4 期

A multicentric, double blind, randomized, placebo controlled clinical study to evaluate the efficacy of Multivitamin Tablet â??Health OKâ?? in healthy male subjects.

Mankind Pharma Limited0 个研究点目标入组 89 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
89

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1) Male Subjects aged 30-55 years(both inclusive) and in good health .
  • 2) Subjects in a sedentary occupation or doing little exercise.
  • 3) Non-smokers
  • 4) Subject not presently on supplementation with multivitamins or similar

排除标准

  • 1) Subject having allergy to soya.
  • 2) Subject currently taking the investigational productor another equivalent multivitamin.(any subject who report multivitamin use must be willing to have
  • a washout for 4 weeks before participating, if not willing to do this they will be excluded.
  • 3) Subject has epilepsy, a thyroid disorder, haemochromatosis or suffers from food allergies. (they must consult their doctor before taking part.)
  • 4) Contraindications or hypersensitivity to the use of the test article or
  • their component.
  • 5) Subjects with history of head injury, diabetes, heart disease,
  • nutritional or herbal allergy or intolerance, neurological, psychological or psychiatric disorder.
  • 6) Subject having alcohol or drug dependence.
  • 7) Subjects currently using of blood thinning medications.

研究者

相似试验